2,176
Views
14
CrossRef citations to date
0
Altmetric
Articles

Enhanced acyclovir delivery using w/o type microemulsion: preclinical assessment of antiviral activity using murine model of zosteriform cutaneous HSV-1 infection

, , , , &
Pages 346-354 | Received 29 Nov 2016, Accepted 27 Mar 2017, Published online: 12 Apr 2017

Figures & data

Table 1. Composition of various microemulsion formulations.

Table 2. The mean scores recorded (ranging from 0 to 4) depending on the degree of infection.

Figure 1. Pseudoternary phase diagram of the system containing IPM, water: DMSO (3:1) and 3:1 weight ratio of Tween 20: Span 20.

Figure 1. Pseudoternary phase diagram of the system containing IPM, water: DMSO (3:1) and 3:1 weight ratio of Tween 20: Span 20.

Figure 2. (A) Transmission electron micrograph depicting spherical globules (Magnification, 12,000x) (B) Particle size distribution of Formulation VI.

Figure 2. (A) Transmission electron micrograph depicting spherical globules (Magnification, 12,000x) (B) Particle size distribution of Formulation VI.

Figure 3. Comparison of cumulative amount permeated per unit area of acyclovir from various formulations in 24 h (The readers are referred to the web version of the article).

Figure 3. Comparison of cumulative amount permeated per unit area of acyclovir from various formulations in 24 h (The readers are referred to the web version of the article).

Figure 4. Comparison of flux, skin retention and permeability coefficient of various formulations through mice. (The readers are referred to the web version of the article).

Figure 4. Comparison of flux, skin retention and permeability coefficient of various formulations through mice. (The readers are referred to the web version of the article).

Figure 5. Histopathological photographs showing absence of any histological and pathological changes (a) Control untreated skin (b) skin treated with Formulation VI (magnification, ×100). (The readers are referred to the web version of the article).

Figure 5. Histopathological photographs showing absence of any histological and pathological changes (a) Control untreated skin (b) skin treated with Formulation VI (magnification, ×100). (The readers are referred to the web version of the article).

Figure 6. Visual evaluation of eradication of infection (a) Mice showing ulcerative lesions due to HSV infection (b) mice treated with once daily application of Formulation VI (c) mice treated with five times application of marketed cream. (The readers are referred to the web version of the article).

Figure 6. Visual evaluation of eradication of infection (a) Mice showing ulcerative lesions due to HSV infection (b) mice treated with once daily application of Formulation VI (c) mice treated with five times application of marketed cream. (The readers are referred to the web version of the article).

Figure 7. Reduction in mean infection score after treatment with Formulation VI. (The readers are referred to the web version of the article).

Figure 7. Reduction in mean infection score after treatment with Formulation VI. (The readers are referred to the web version of the article).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.